Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II b Study of Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease

NCT06663722 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT06663722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06663722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II b Study of Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
Lead sponsor
University of Miami
Phase
Phase 2
Overall status
Recruiting
Start date
May 5, 2025
Completion date
May 5, 2030
Enrollment
49 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cgvhd, chronic graft versus host disease